|
|
|
Volumn 19, Issue 6, 2005, Pages 759-770
|
|
Revisiting induction chemotherapy for head and neck cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2B INTERFERON;
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
FLUOROURACIL;
FOLINIC ACID;
IFOSFAMIDE;
METHOTREXATE;
PACLITAXEL;
PLATINUM;
TAXANE DERIVATIVE;
ANTINEOPLASTIC AGENT;
TAXOID;
ANEMIA;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL TRIAL;
DRUG EFFICACY;
FEBRILE NEUTROPENIA;
HEAD AND NECK CANCER;
HUMAN;
INFECTION;
LEUKOPENIA;
META ANALYSIS;
MOUTH CAVITY;
MUCOSA INFLAMMATION;
NASOPHARYNX CANCER;
NAUSEA AND VOMITING;
NEPHROTOXICITY;
NEUTROPENIA;
ORGAN PRESERVATION;
RASH;
REVIEW;
SQUAMOUS CELL CARCINOMA;
STOMATITIS;
SYSTEMATIC REVIEW;
HEAD AND NECK TUMOR;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
CLINICAL TRIALS;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
LEUCOVORIN;
PACLITAXEL;
TAXOIDS;
|
|
EID: 24344482116
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (14)
|
|
References (0)
|
